Suchergebnisse - "Burhenne, Jürgen"

PubPharm (120)

1

CYP3A and CYP2C19 Activity Determined by Microdosed Probe Drugs Accurately Predict Voriconazole Clearance in Healthy Adults

enthalten in: Clinical pharmacokinetics | 2023

von Muhareb, A. | Blank, A. | Meid, A. | +5

2

Frailty as a Marker for the Plasma Concentrations of Direct Oral Anticoagulants in Older Patients: Results of an Exploratory Study

enthalten in: Drugs & aging | 2023

von Eidam, A. | Marji, J. | Benzinger, P. | +8

3

Quantification of the Time Course of CYP3A Inhibition, Activation, and Induction Using a Population Pharmacokinetic Model of Microdosed Midazolam Continuous Infusion

enthalten in: Clinical pharmacokinetics | 2022

von Nassar, Y. | Hohmann, N. | Michelet, R. | +7

4

Evaluation of CYP2C19 activity using microdosed oral omeprazole in humans

enthalten in: European journal of clinical pharmacology | 2022

von Elbe, A. | Foerster, K. | Blank, A. | +4

5

Perpetrator Characteristics of Azole Antifungal Drugs on Three Oral Factor Xa Inhibitors Administered as a Microdosed Cocktail

enthalten in: Clinical pharmacokinetics | 2021

von Rohr, B. | Foerster, K. | Blank, A. | +4

6

Intact plasma quantification of the large therapeutic lipopeptide bulevirtide

enthalten in: Analytical & bioanalytical chemistry | 2021

von Sauter, M. | Blank, A. | Stoll, F. | +3

7

Midazolam Pharmacokinetics in Obese and Non-obese Children and Adolescents

enthalten in: Clinical pharmacokinetics | 2019

von Gade, C. | Sverrisdóttir, E. | Dalhoff, K. | +8

8

Microdosed Cocktail of Three Oral Factor Xa Inhibitors to Evaluate Drug–Drug Interactions with Potential Perpetrator Drugs

enthalten in: Clinical pharmacokinetics | 2019

von Mikus, G. | Foerster, K. | Schaumaeker, M. | +3

9

Elucidating the beneficial effects of melphalan, adriamycin, and corticoids in combination with bortezomib against multiple myeloma in vitro

enthalten in: Naunyn-Schmiedeberg's archives of pharmacology | 2018

von Schäfer, J. | Burhenne, J. | Weiss, J. | +1

10

A physiologically based pharmacokinetic and pharmacodynamic (PBPK/PD) model of the histone deacetylase (HDAC) inhibitor vorinostat for pediatric and adult patients and its application for dose specification

enthalten in: Cancer chemotherapy and pharmacology | 2017

von Moj, D. | Britz, H. | Burhenne, J. | +4

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[12]